Cargando…
Rationale and Clinical Implications of Fluorescein-Guided Supramarginal Resection in Newly Diagnosed High-Grade Glioma
Current standard of care for glioblastoma is surgical resection followed by temozolomide chemotherapy and radiation. Recent studies have demonstrated that >95% extent of resection is associated with better outcomes, including prolonged progression-free and overall survival. The diffusely infiltra...
Autores principales: | Wang, Linda M., Banu, Matei A., Canoll, Peter, Bruce, Jeffrey N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187787/ https://www.ncbi.nlm.nih.gov/pubmed/34123831 http://dx.doi.org/10.3389/fonc.2021.666734 |
Ejemplares similares
-
Fluorescein-guided resection of newly diagnosed high-grade glioma: Impact on extent of resection and outcome
por: Schebesch, Karl-Michael, et al.
Publicado: (2022) -
Fluorescein-guided surgery for high-grade glioma resection: a five-year-long retrospective study at our institute
por: Xi, Chen, et al.
Publicado: (2023) -
Fluorescein-guided surgery for the resection of pilocytic astrocytomas: A multicentric retrospective study
por: Falco, Jacopo, et al.
Publicado: (2022) -
Fluorescein for resection of high-grade gliomas: A safety study control in a single center and review of the literature
por: Francaviglia, Natale, et al.
Publicado: (2017) -
Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas
por: Qaddoumi, Ibrahim, et al.
Publicado: (2014)